Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
2.360
-0.080 (-3.28%)
Feb 21, 2025, 4:00 PM EST - Market closed
Metagenomi Revenue
Metagenomi had revenue of $11.51M in the quarter ending September 30, 2024, a decrease of -6.87%. This brings the company's revenue in the last twelve months to $55.08M, up 45.13% year-over-year. In the year 2023, Metagenomi had annual revenue of $44.76M with 160.21% growth.
Revenue (ttm)
$55.08M
Revenue Growth
+45.13%
P/S Ratio
1.05
Revenue / Employee
$233,390
Employees
236
Market Cap
88.32M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 44.76M | 27.56M | 160.21% |
Dec 31, 2022 | 17.20M | 16.96M | 6,978.19% |
Dec 31, 2021 | 243.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMGX News
- 11 days ago - Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference - GlobeNewsWire
- 5 weeks ago - Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones - GlobeNewsWire
- 5 weeks ago - Metagenomi Announces New Appointment to its Board of Directors - GlobeNewsWire
- 6 weeks ago - Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV” - GlobeNewsWire
- 2 months ago - Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting - GlobeNewsWire
- 3 months ago - Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm - Accesswire
- 3 months ago - FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi - Business Wire